Insider Transactions and Holdings
-
Entity Type
-
Individual
-
Role
-
CFO and Interim CEO
-
Stock Symbol
-
GANX on Nasdaq
Gene Mack - trading volume in the past year for Gain Therapeutics, Inc.
| Class |
Num Shares |
Value |
Price $ |
Transaction Date |
Ownership |
Underlying Class |
Underlying Amount |
| Common Stock |
14.4K |
$14.5K |
$1.01 |
Aug 9, 2024 |
Direct |
|
|
| Employee Stock Option (right to buy) |
200K |
|
|
Apr 8, 2024 |
Direct |
Common Stock |
|
| Sym |
Class |
Transaction |
% |
Value $ |
* Price $ |
Shares |
Shares After |
Date |
Ownership |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.